Novo Nordisk’s new weight-loss pill Amycretin beats Wegovy in early trial
The highly anticipated new obesity pill shows the potential for greater and faster weight loss than Wegovy. There is a new ...
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for ...
Novo Nordisk’s Wegovy Gets EU Backing to Treat Obesity-Related Heart Failure
Novo Nordisk said European regulators support the use of its blockbuster weight-loss drug Wegovy to help reduce heart failure ...
Novo Nordisk has mitigation plans to minimize disruption from port strikes, CNBC reports
Danish drugmaker Novo Nordisk has mitigation plans in place to minimize or prevent any disruption to its production due to ...
STAT21d
Novo Nordisk’s amylin pill leads to substantial weight loss in early study
Novo Nordisk on Tuesday reported that its ... For comparison, Novo’s blockbuster Wegovy led to 15% weight loss in its pivotal Phase 3 trial lasting over a year.
Novo Nordisk CEO grilled over steep weight loss drug costs
Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on ...
Forbes20d
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial
Ozempic maker Novo Nordisk on Wednesday said data showed its hotly anticipated weight loss pill prompts greater and more rapid weight loss than its blockbuster treatment Wegovy, amid ...
New York Sun4h
Ozempic and Other Weight-Loss Wonder Drugs At Risk as Port Strike Threatens Pharmaceutical Supply Chain
The longshoreman’s strike shutting down ports along the East and Gulf Coasts may cause a significant shortage of widely used ...